Found 32 matching trials
NEPC Study: An Exploratory Safety and Efficacy Study With PSMA, SSTR2 and GRPR Targeted Radioligand Therapy in Metastatic Neuroendocrine Prostate Cancer. PHASE1 The purpose of this study is to evaluate the change in the expression of tr...
Show More Status
Active Not Recruiting
Location
Nebraska Cancer Specialists
Learn More & Join Trial
Phase 2 Randomized Trial of Flexible Dosing Schedule of 177Lu-PSMA-617 for the Treatment of Metastatic Castration-Resistant Prostate Cancer (FLEX-MRT) PHASE2 In advanced metastatic castration resistant prostate cancer (mCRPC) progres...
Show More Location
UCLA / Jonsson Comprehensive Cancer Center
Learn More & Join Trial
Study to Assess [177Lu]Lu-PSMA-R2 (AAA602) and [225Ac]Ac-PSMA-R2 (AAA802) in Participants With PSMA-positive HRLPC PHASE1 The purpose of this trial is to learn more about the effects of AAA602 and ...
Show More Location
Multiple Locations
Learn More & Join Trial
68Ga-PSMA-11 PET/CT Screening Prior to 177Lu-PSMA-617 Therapy for Patients With Metastatic Castrate Resistant Prostate Cancer PHASE3 This phase III study provides access to 68Ga-PSMA-11 positron emission tomo...
Show More Location
Mayo Clinic in Rochester
Learn More & Join Trial
Schedule De-Escalation of 177Lu-PSMA-617 for the Treatment of Metastatic Castrate Resistant Prostate Cancer PHASE2 This phase II trial studies how to improve the usage of Lu 177 vipivotide t...
Show More Location
Mayo Clinic in Rochester
Learn More & Join Trial
Gallium Ga 68-labeled PSMA-11 PET/CT in Detecting Recurrent Prostate Cancer in Patients After Initial Therapy PHASE3 This clinical trial studies how well gallium Ga 68-labeled prostate-specifi...
Show More Location
UCLA / Jonsson Comprehensive Cancer Center
Learn More & Join Trial
Effect of Androgen Receptor Signaling Inhibitors on 68Ga-PSMA-11 PET/CT Imaging in Patients With Castration-Resistant Prostate Cancer PHASE1 This trial studies the effect of androgen receptor signaling inhibitors on ...
Show More Location
UCLA / Jonsson Comprehensive Cancer Center
Learn More & Join Trial
Escalating Cycle 1 Dose of Lu-177-PSMA-617 for the Treatment of Metastatic Castration Resistant Prostate Cancer PHASE1 This phase I trial studies the safety, side effects, and treatment cycle 1 ...
Show More Location
University of Michigan Rogel Cancer Center
Learn More & Join Trial
177Lu-PSMA-617 Managed Access Program for mCRPC Patients N/A The purpose of this Cohort Treatment Plan is to allow access to 177Lu-PSMA-...
Show More Status
No Longer Available
Location
Multiple Locations
Learn More & Join Trial
68Ga-PSMA-11 Efficacy in Detecting BCR Prostate Cancer in Chinese Patients PHASE3 This is a prospective, open-label, single-arm, multicenter bridging study i...
Show More Location
Peking University First Hospital
Learn More & Join Trial